What is ARWR's five-year median P/S?

14.3x. Half of ARWR's weekly readings over the last five years were higher and half were lower. This page has 403 weekly readings, from Feb 4, 2019 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ARWR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Arrowhead Pharmaceuticals Inc (ARWR) valuation history

Health Care

$58.02

Latest weekly close · Market cap $8.3B

Within its usual range

As of Oct 24, 2026

ARWR's P/S of 12.4x is lower than 67% of its weekly readings over the last five years.

Weekly P/S with its 5-year range

P/S each weekMiddle half of the last 5 years5-year median 14.3×

5-year median: 14.3×
10-year median: 20.9×
5-year low to high: 3.7×–156.6×
Versus 5-year median: -13%

P/S

33rdpercentile

of its weekly readings over the last five years

Within its usual range

Growth, last 12 months vs the year before

Revenue: +17%slowing
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ARWR P/S at each year-end
Year-end	P/S	5-year percentile
Dec 29, 2025	10.9×	17
Dec 30, 2024	n/a	Too little history
Dec 25, 2023	13.6×	17
Dec 26, 2022	17.6×	17
Dec 27, 2021	49.7×	60
Dec 28, 2020	87.8×	98
Dec 30, 2019	36.0×	66

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare ARWR with peers

Health Care peers of ARWR on P/S
Stock	P/S	Versus its own history	5-year percentile
ABBVAbbVie	7.8×	Historically high	100
AMGNAmgen	6.4×	Historically high	99
BBIOBridgebio Pharma Inc	18.8×	Below its usual range	17
BIIBBiogen	3.7×	Above its usual range	80
BMRNBioMarin Pharmaceutical Inc	3.2×	Historically low	2

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on ARWR

No articles about ARWR yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ARWR's current P/S?: ARWR's P/S of 12.4x is lower than 67% of its weekly readings over the last five years.
What is ARWR's five-year median P/S?: 14.3x. Half of ARWR's weekly readings over the last five years were higher and half were lower. This page has 403 weekly readings, from Feb 4, 2019 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ARWR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.